Spectri

Specialisation

Retina and Vitreous.

Full title

Phase III, multicentre, randomised, double-blind, sham-controlled trial to assess the efficacy and safety of lampalizumab administered by intravitreal injection to patients with geographic atrophy secondary to age-related macular degeneration.

Promoter

Roche Pharma.

Start date

September 2014.

Researchers

Main: Dr Rafael Navarro.